Trial NCT02797704

View at ClinicalTrials.gov 
Org. Study IDs: 0134-16-RMC

Last trial update was posted on 2019-09-16

MeSH Interventions

Aflibercept

MeSH Conditions

Corneal Neovascularization Neovascularization, Pathologic

Other Conditions


Stopping Reasons

the treatment was found to be inefficient for all recruited patients

Limitations And Caveats

N/A

Result Publications


Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID